These findings suggest that autophagy signaling appears to be a promising target for intervention in sevoflurane‐induced cognitive impairment in the early tau pathology, which lays the foundation for further study of the underlying mechanisms. The gene discussed is MAPT; the disease is Cognitive impairment.